Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular CarcinomaMin Yu, Zonghai Li, Hong Luo et al.|Molecular Therapy|2017Cited by 184